Ascentage Pharma Group International announced a private placement of 24,307,322 common shares at a price of $3.08549 for the gross proceeds of $74,999,998.95778 on June 20, 2024. The transaction included participation from new investor Takeda International - Uk Branch.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.55 HKD | +0.99% |
|
+3.02% | -6.41% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-6.41% | 1.01B | |
+15.20% | 121B | |
+19.67% | 113B | |
+18.95% | 26.02B | |
-23.86% | 19.39B | |
-19.03% | 15.91B | |
-20.90% | 15.09B | |
-46.14% | 15.06B | |
+63.85% | 14.93B | |
+4.49% | 13.85B |
- Stock Market
- Equities
- 6855 Stock
- News Ascentage Pharma Group International
- Ascentage Pharma Group International announced that it has received $74.999999 million in funding from Takeda International - Uk Branch